Actuate Therapeutics, Inc. Line of Credit Facility, Remaining Borrowing Capacity
Actuate Therapeutics, Inc. (ACTU) had Line of Credit Facility, Remaining Borrowing Capacity of $99.50 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity · last filed 2026-05-14
- 2026-03-31: Line of Credit Facility, Remaining Borrowing Capacity $99.50M.
| Period end | Line of Credit Facility, Remaining Borrowing Capacity |
|---|---|
| 2026-03-31 | $99.50M 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |